David Hoel, OD
Optometrist · Chillicothe, MONPI 1649469602
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Johnson & Johnson Vision Care, Inc. accounts for 89.4% of it on its own, with 5 other manufacturers making up the rest.
Across 77 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$1K
- Rxsight Inc$87
- Alcon$24
- Johnson & Johnson Surgical Vision, Inc.$24
- Carl Zeiss Meditec AG$19
- Bayer$13
What the payments were for
- Food & beverage$1,56599%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 72 | $1,417 |
| Rxsight Inc | 1 | $87 |
| Alcon | 1 | $24 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $24 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Bayer | 1 | $13 |
How this compares
$1,585 in reported general payments places this provider in the 70th percentile of 1,030 optometrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 33 | $11,732 |
| RestasisCyclosporine | 11 | $8,458 |
| Cyclosporine | 12 | $3,774 |
| Loteprednol Etabonate | 13 | $2,196 |
| Prednisolone Acetate | 38 | $1,275 |
| Latanoprost | 164 | $657 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 24 | $451 |
| Timolol Maleate | 61 | $445 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 13 | $418 |
| Brimonidine Tartrate | 35 | $231 |
| ErythromycinErythromycin Base | 16 | $175 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 16 | $157 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Chillicothe
- Andrew BiondoKirkwood$300K
- John McGrealSaint Louis$126K
- Alana KellerWildwood$94K
- Sarah HubbardChesterfield$91K
- Ariel CerenzieSaint Louis$76K
- Geoffrey PowellKansas City$55K
- Thomas HobbsSedalia$53K
- Heather WebsterColumbia$52K
- Sean MulqueenyCreve Coeur$45K
- Glen LojkaEllisville$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.